1. Home
  2. CTRA vs EXAS Comparison

CTRA vs EXAS Comparison

Compare CTRA & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coterra Energy Inc.

CTRA

Coterra Energy Inc.

HOLD

Current Price

$25.49

Market Cap

19.6B

Sector

Energy

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.78

Market Cap

19.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRA
EXAS
Founded
1989
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.6B
19.3B
IPO Year
1990
N/A

Fundamental Metrics

Financial Performance
Metric
CTRA
EXAS
Price
$25.49
$101.78
Analyst Decision
Buy
Buy
Analyst Count
16
20
Target Price
$32.81
$80.25
AVG Volume (30 Days)
6.9M
3.0M
Earning Date
02-23-2026
02-18-2026
Dividend Yield
3.48%
N/A
EPS Growth
31.20
N/A
EPS
2.17
N/A
Revenue
$6,666,000,000.00
$3,082,033,000.00
Revenue This Year
$47.54
$19.40
Revenue Next Year
$5.27
$13.51
P/E Ratio
$11.67
N/A
Revenue Growth
25.92
14.47
52 Week Low
$22.33
$38.81
52 Week High
$29.95
$102.66

Technical Indicators

Market Signals
Indicator
CTRA
EXAS
Relative Strength Index (RSI) 45.42 82.28
Support Level $24.74 $101.51
Resistance Level $26.70 $101.89
Average True Range (ATR) 0.58 0.35
MACD -0.11 -1.01
Stochastic Oscillator 37.50 63.64

Price Performance

Historical Comparison
CTRA
EXAS

About CTRA Coterra Energy Inc.

Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and natural gas liquids (NGLs). Its operations are mainly concentrated in areas with hydrocarbon resources, which are conducive to multi-well, repeatable development programs, and include the Permian Basin located in Texas and New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin located in the mid-continent region in Oklahoma. The company operates in one segment, oil and natural gas development, exploration, and production, in the continental U.S.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: